Published in Thromb Haemost on January 01, 1994
Usefulness of D-dimer, blood gas, and respiratory rate measurements for excluding pulmonary embolism. Thorax (1998) 2.24
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. ACS Nano (2013) 1.12
Diagnosing pulmonary embolism. BMJ (1994) 1.00
Predictive Value of the Rapid Whole Blood Agglutination D-Dimer Assay (AGEN SimpliRED) in Community Outpatients with Suspected Deep Venous Thrombosis. Perm J (2006) 0.96
Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure and thromboembolic events in primary care: a cluster-randomised controlled trial. BMC Fam Pract (2011) 0.91
Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers. J Am Chem Soc (2014) 0.91
Role of fibrin D-dimer testing in emergency medicine. Emerg Med J (2003) 0.89
The role of d-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility. J Transl Med (2004) 0.83
Successful diagnosis of thromboembolism before surgery in a woman with clear cell adenocarcinoma of the endometrium. Int J Clin Oncol (2005) 0.82
Platelet activation after presyncope by lower body negative pressure in humans. PLoS One (2014) 0.82
Early activation of the coagulation system during lower body negative pressure. Clin Physiol Funct Imaging (2009) 0.79
Comparison of venous thromboembolism after total hip arthroplasty between ankylosing spondylitis and osteoarthritis. Biomed Res Int (2014) 0.78
Diagnostic value of D-dimer and antithrombin-III levels in predicting prosthetic heart valve thrombosis. Tex Heart Inst J (2003) 0.77
D Dimer in acute care. Int J Crit Illn Inj Sci (2014) 0.76
Utility of d-dimer in the diagnosis of patients with chronic thromboembolic pulmonary hypertension. Open Respir Med J (2009) 0.76
Relationship between disease severity and D-dimer levels measured with two different methods in pulmonary embolism patients. Multidiscip Respir Med (2010) 0.75
Study of clinical profile and management of patients with pulmonary embolism - single center study. Indian Heart J (2014) 0.75
Suspected deep vein thrombosis: a management algorithm for the accident and emergency department. J Accid Emerg Med (1999) 0.75
Rapid D-dimer testing as an adjunct to clinical findings in excluding pulmonary embolism. Thorax (1999) 0.75
Rebuttal of the article of Bounameaux et al. Thromb Haemost (1994) 0.75
Interface flow process audit: using the patient's career as a tracer of quality of care and of system organisation. Int J Integr Care (2004) 0.75
[Differential diagnosis of leg edema]. Wien Med Wochenschr (2016) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature (1998) 5.62
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2009) 4.95
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost (2007) 2.86
Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No. J Thromb Haemost (2004) 2.68
Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet (1999) 2.46
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost (2010) 2.43
Antibiotic prophylaxis before invasive dental procedures in patients with arthroplasties of the hip and knee. J Bone Joint Surg Br (2008) 2.35
Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med (2001) 2.23
Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med (2001) 2.11
NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost (2014) 2.05
Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet (1991) 1.99
Diagnosing deep vein thrombosis: the case for compression ultrasonography limited to the proximal veins. J Thromb Haemost (2004) 1.71
Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism. Lancet (2000) 1.63
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Ethical difficulties in clinical practice: experiences of European doctors. J Med Ethics (2007) 1.57
Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet (1996) 1.54
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost (2006) 1.54
Tissue factor expression in human leukemic cells. Leuk Res (1996) 1.53
New oral antithrombotics: a need for laboratory monitoring. Against. J Thromb Haemost (2010) 1.48
Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost (2000) 1.45
Effects of statins on adhesion molecule expression in endothelial cells. J Thromb Haemost (2003) 1.45
LMWH contra LMWH: superior, equivalent or non-inferior? J Thromb Haemost (2003) 1.38
Effects of age on the performance of common diagnostic tests for pulmonary embolism. Am J Med (2000) 1.33
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
D-Dimer for venous thromboembolism diagnosis: 20 years later. J Thromb Haemost (2008) 1.27
Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis. Am J Med (2001) 1.22
Factor VIII gene inversions causing severe hemophilia A originate almost exclusively in male germ cells. Hum Mol Genet (1994) 1.19
D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med (1997) 1.14
Influence of age on the cost-effectiveness of diagnostic strategies for suspected pulmonary embolism. J Thromb Haemost (2007) 1.12
Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol (2000) 1.11
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories. Thromb Res (2011) 1.10
Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol (1989) 1.08
Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med (1996) 1.05
Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis? Neurology (2003) 1.04
Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost (1995) 1.04
Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med (2007) 1.04
Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography? Arch Intern Med (2000) 1.03
Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost (2007) 1.03
Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost (2010) 1.02
Should prophylaxis be used in adolescent and adult patients with severe haemophilia? An European survey of practice and outcome data. Haemophilia (2007) 1.02
Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregation. Eur Respir J (2002) 1.01
D-dimer testing in suspected venous thromboembolism: an update. QJM (1997) 0.99
D-dimer levels during delivery and the postpartum. J Thromb Haemost (2005) 0.99
Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med (1996) 0.98
Performances of the VIDAS D-dimer new assay for the exclusion of venous thromboembolism. Thromb Haemost (2001) 0.98
Contribution of noninvasive evaluation to the diagnosis of pulmonary embolism in hospitalized patients. Eur Respir J (1999) 0.97
D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res (1993) 0.97
Should the D-dimer cut-off value be increased in elderly patients suspected of pulmonary embolism? Thromb Haemost (2001) 0.97
Congenital alpha(2)-plasmin inhibitor deficiencies: a review. Br J Haematol (2001) 0.96
Myo-inositol transport in Aerobacter aerogenes. Biochim Biophys Acta (1972) 0.95
Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost (2009) 0.94
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients? J Thromb Haemost (2009) 0.93
The coagulopathy of massive transfusion. Vox Sang (2005) 0.93
Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hémostase et la Thrombose). Thromb Haemost (1995) 0.92
How and when to monitor a patient treated with low molecular weight heparin. Semin Thromb Hemost (2001) 0.92
Transport of cyclitols by a proton symport in Klebsiella aerogenes. Eur J Biochem (1977) 0.92
Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol (1993) 0.92
Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol (2000) 0.91
VIDAS D-dimer: fast quantitative ELISA for measuring D-dimer in plasma. Clin Chem (1996) 0.91
Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. J Intern Med (2012) 0.91
Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age. J Thromb Haemost (2005) 0.90
Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies. J Thromb Haemost (2004) 0.90
Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost (2005) 0.90
Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. J Thromb Haemost (2012) 0.89
Procoagulant activity in bronchoalveolar fluids: no relationship with tissue factor pathway inhibitor activity. Thromb Res (1992) 0.89
Stereospecificity of the myo-inositol transport system of Aerobacter aerogenes and sensitivity towards sulfhydryl reagents. Experientia (1974) 0.88
D-dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res (1994) 0.88
Diagnostic value of plasma D-dimer in suspected pulmonary embolism. Lancet (1988) 0.88
Measurement of plasma D-dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty. Blood Coagul Fibrinolysis (1998) 0.88
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med (2000) 0.87
von Willebrand factor: from cell biology to the clinical management of von Willebrand's disease. Crit Rev Oncol Hematol (1999) 0.87
Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin-induced coagulation of plasma. Thromb Res (1983) 0.87
Antithrombotic prophylaxis in patients undergoing laparoscopic cholecystectomy. Thromb Res (1997) 0.87
Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk? Haematologica (2004) 0.87
European curriculum for thrombosis and haemostasis. Haemophilia (2009) 0.86
[Perspectives and challenges to guarantee training and renewal in general internal medicine]. Rev Med Suisse (2009) 0.86
Risk of major bleeding in unselected patients with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 0.86
Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T. Blood (2001) 0.85